Search clinical trials for: Optive Fusion® Lubricant Eye Drops (Unit Dose)

Total 70 results

1
2
›

Allergan

Completed

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Dry Eye Syndromes

United States
Chang Gung Memorial Hospital

Completed

Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease

Cataract | Dry Eye Disease

Taiwan
Alcon Research

Completed

Acute Comfort of Lubricant Eye Drop FID 111421

Dry Eye
Alcon Research

Withdrawn

Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time

Dry Eye
Allergan

Completed

Efficacy and Acceptability of Two Lubricant Eye Drops

Dry Eye Syndromes

United States
Alcon Research

Completed

Clinical Outcomes Following Treatment With SYSTANE® BALANCE

Dry Eye
Alcon Research

Completed

Acute Comfort and Blur of Systane and Optive

Dry Eye
Alcon Research

Completed

Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops

Dry Eye

United States
Alcon Research

Completed

The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

Dry Eye

United States
Alcon Research

Completed

Acute Comfort of Lubricant Eye Drops FID 112903

Dry Eye

United States
Southern California College of Optometry at Marshall...
Alcon Research

Completed

The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

United States
Alcon Research

Completed

Evaluation of FID 114657 on Tear Film Lipid Layer Thickness

Dry Eye
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
Alcon Research

Completed

Evaluation of the Repeated Usage of Systane Ultra Eyedrop

Dry Eye
Tufts Medical Center

Recruiting

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests (PreDICT)

Dry Eye

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

Dry Eye

United States
Alcon Research

Completed

Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye

Dry Eye Syndrome
Alcon Research

Completed

An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye

Dry Eye Syndrome
Alcon Research

Completed

Systane Complete Multi-symptom Relief

Dry Eye Disease

United States
Alcon Research

Completed

SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers

Dry Eye Syndrome
Alcon Research

Completed

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

Dry Eye
National University of Malaysia

Unknown

Umbilical Cord Serum Versus Conventional Eyedrops

Dry Eye Syndromes

Malaysia
Innovative Medical

Completed

A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens

Dry Eye

United States
Alcon Research
Optometric Technology Group Ltd

Completed

Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion

Dry Eye

United States, United Kingdom
Alcon Research

Completed

Systane Hydration in Subjects Undergoing Cataract Surgery

Cataract | Dry Eye Disease

Spain
University of California, Berkeley
Alcon Research

Completed

Artificial Tears, Tear Lipids and Tear Film Dynamics (AlconAT)

Dry Eye

United States
Alcon Research

Completed

In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients

Dry Eye Syndrome
Alcon Research

Completed

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

Dry Eye Syndrome
Alcon Research

Completed

Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery

Dry Eye | Cataract Surgery
Alcon Research

Completed

Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%

Dry Eye Syndrome
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops

Visual Acuity

United States
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Dry Eye Syndromes

United States
Bp Consulting, Inc

Completed

Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

Comfort, Vision and Wear Time

United States
The University of New South Wales

Completed

The Effect of Manuka Eye Drops on Tear Film Properties

Dry Eye Syndrome

Australia
Southern California College of Optometry at Marshall...
Allergan

Completed

The Visual Effect of an Investigational Artificial Tear in the Tear Layer.

Dry Eye Disease

United States
Allergan

Completed

Optive Brand For Day And Night Dry Eye Management

Dry Eye

United Kingdom
Peloton Therapeutics, Inc., a subsidiary of Merck...

Active, not recruiting

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Kidney Cancer | Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Cell Cancer Metastatic | Kidney | Clear Cell Renal Cell Carcinoma (ccRCC) | Renal Cell Carcinoma Recurrent | Renal Cell Cancer, Recurrent

United States
Michael D. Straiko, MD
Lions VisionGift Research; Eye Bank Association of America

Recruiting

Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy

Fuchs Endothelial Dystrophy

United States
Alcon Research

Completed

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Dry Eye Disease

United States
L.V. Prasad Eye Institute
Allergan

Recruiting

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Congenital Hereditary Endothelial Dystrophy of Cornea

India
University of Waterloo
Advanced Vision Research

Completed

A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) (DUNLIN)

Dry Eye Syndromes

Canada
Allergan

Completed

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (IMPACT)

Dry Eye Syndromes

United States
Bausch & Lomb Incorporated
Synteract, Inc.

Completed

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Keratoconjunctivitis Sicca

United States
Allergan

Completed

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Dry Eye Disease (DED)

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches (OCUREA2)

Corneal Diseases

France
Diego Dias de Araújo
Conselho Nacional de Desenvolvimento Científico e Tecnológico; State University...

Unknown

Effect of Nursing Care on Prevention of Dry Eye

Dry Eye Syndromes

Brazil
Eye & ENT Hospital of Fudan University

Recruiting

CG-101 Eye Drops in the Treatment of Dry Eye Syndrome

Dry Eye

China
M.D. Anderson Cancer Center
Allergan

Withdrawn

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Epiphora
Farwaniya Hospital

Completed

Topical Cyclosporine-A for Management of Epiphora (CSA-epiphora)

Epiphora

Kuwait
Optometric Technology Group Ltd
Allergan

Completed

Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints

Contact Lens Related Dry Eye Syndrome

United Kingdom

1
2
›

3

Subscribe